CYTK
Cytokinetics Inc
67.60$
-1.8%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -13.3% | +47.6% | +73.3% | -28.4% | +37.2% | +84.2% | +57.6% | +20.6% | -18.8% | +70.0% | +1.6% | |
| – | -13.7% | +40.3% | +72.9% | -24.3% | +12.6% | +102.9% | +13.0% | +48.4% | -21.0% | +76.4% | -17.2% | |
| – | +221.9% | +2.8% | +87.2% | -66.3% | -13.8% | +127.8% | +35.8% | -41.8% | +72.3% | -16.1% | +29.2% | |
| – | +33.9% | +40.2% | +72.1% | -26.1% | +13.3% | +106.1% | +1.6% | +65.9% | -21.4% | +75.0% | -18.0% | |
| – | -100.0% | +100.0% | +4,533.3% | +510.2% | -23.9% | -14.4% | +1,072.4% | -99.7% | +772.8% | +1,197.7% | +6.7% | |
| – | -100.0% | – | – | -678,500,100.0% | – | – | – | – | – | – | – | |
| – | +7.0% | +107.7% | -1.9% | -10.2% | +41.4% | +194.6% | +449.0% | +9.8% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +14.0% | +62.5% | +144.1% | +0.1% | +62.4% | +39.8% | +42.1% | +87.9% | +7.8% | +27.0% | +35.6% | |
| – | +32.7% | +5.1% | -2.4% | -31.6% | +17.3% | +19.9% | +130.3% | +17.8% | +21.3% | +75.0% | +12.7% | |
| – | +64.4% | +11.7% | +110.1% | -50.4% | +77.1% | -39.7% | +433.7% | -7.2% | +102.9% | +9.0% | +97.7% | |
| – | +64.4% | +89.3% | +24.0% | -28.3% | +116.8% | -1.3% | +162.0% | +21.5% | -16.0% | -5.3% | +9.7% | |
| – | – | +87.0% | +16.1% | +25.3% | +13.2% | +2.6% | +2.5% | +34.7% | +851.8% | +6.3% | +72.9% | |
| – | -25.5% | +37.6% | +16.4% | -76.4% | -142.2% | – | +115.1% | -144.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +8.7% | +9.7% | +16.1% | +10.2% | +5.8% | +12.1% | +19.2% | +16.8% | +7.5% | +16.0% | +7.3% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.